Leatt (OTCMKTS:LEAT - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.08 earnings per share (EPS) for the quarter, Zacks reports. Leatt had a return on equity of 5.87% and a net margin of 4.12%.
Here are the key takeaways from Leatt's conference call:
- Revenue grew 41% to $61.91 million in 2025 with Q4 sales of $16.0 million (up ~43% YoY), marking consecutive quarters of double-digit growth driven by international demand and distributor restocking.
- Profitability improved materially—full-year net income was $3.26 million (up 248%) and gross margin rose to 44% (Q4 gross margin 46%), turning prior-year losses into quarterly and annual profits.
- Broad-based product momentum: helmets +59%, body armor +29% (footwear +40%), neck braces +18% and other parts/accessories +56%, with body armor representing 47% of 2025 revenues.
- Management plans to expand its global sales and marketing team and expects working capital and operating costs to rise (up 12%), while flagging tariff/geopolitical uncertainty—company reports $13.23 million in cash and an extended $750k buyback to support liquidity.
Leatt Stock Up 5.9%
Shares of LEAT stock opened at $9.21 on Wednesday. The business has a 50-day moving average price of $9.09 and a two-hundred day moving average price of $10.18. Leatt has a 12-month low of $5.01 and a 12-month high of $14.50. The firm has a market cap of $57.38 million, a P/E ratio of 25.58 and a beta of 0.92.
Leatt Company Profile
(
Get Free Report)
Leatt OTCMKTS: LEAT is a designer and manufacturer of protective sports gear, specializing in advanced safety equipment for high-impact activities such as motocross, mountain biking, and snow sports. The company's product portfolio includes the patented Leatt Brace® neck protection system, impact-absorbing body armor, full-face and off-road helmets, goggles, gloves, and riding apparel. These offerings are engineered to mitigate the risk of spinal and head injuries, combining biomechanical research with lightweight materials and user-focused design.
Founded by Dr.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Leatt, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leatt wasn't on the list.
While Leatt currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.